The latest news from academia, regulators
research labs and other things of interest
Posted: Jul 14, 2011
NanoSight is recognised as an ISO9001 Certified Company
(Nanowerk News) NanoSight, leading manufacturers of unique nanoparticle characterization technology, announces they have received notification of being recognised as an ISO9001 certified company.
The ISO 9000 family addresses "Quality management." When a company is given recognition as a certified company, the organization has met the customer's quality requirements and applicable regulatory requirements, while aiming to enhance customer satisfaction and achieve continual improvement of its performance in pursuit of these objectives.
Speaking on this exciting news, NanoSight's CEO, Jeremy Warren, said, "I have worked in firms where ISO 9001 compliance has eventually been forced upon them by customer's increasing demands. For me, the ISO structure of objectives and control is a prerequisite to business growth; a genuinely helpful tool. Whether it's a calibration protocol or a measure of customer satisfaction, having it written down in one place helps everybody. Our staff understands they can always suggest modifications and updates, so not only are the systems flexible, they are also up to date. When users know that the copies of work instructions are current, they trust them and the system is worked hard. We have been using these systems since start-up, seven years ago and they have proved expandable and flexible. ISO 9001 increasingly serves the international nature of the business, operating worldwide and necessarily across a score of time zones. It is especially useful in training dist ributors to maintain and support our instrumentation."
It was also interesting to hear the comments from the ISO9001 quality systems consultant, Tony Del Gallo, who worked with NanoSight and led them through the process. He said "It was clear from the outset that NanoSight embraced a philosophy of quality systems. Most of the paperwork was in place at my first visit, and was in daily use. I had direct access to the CEO from day one. As an engineer, Jeremy Warren understands the value of clearly-drafted specifications and has championed this need as NanoSight has grown. As a consequence, this was one of the fastest and most trouble free certifications I have done and this is rare amongst technically-driven and high growth firms".
To learn about how NanoSight is using this certification to the betterment of their doing business, please visit their web site. Also to learn more about particle characterization using NanoSight's unique nanoparticle tracking analysis solutions, please visit the company website (www.nanosight.com) and register for the latest issue of NanoTrail, the company's electronic newsletter.
NanoSight delivers the world's most versatile and proven multi-parameter nanoparticle analysis in a single instrument.
NanoSight's "Nanoparticle Tracking Analysis" (NTA) detects and visualizes populations of nanoparticles in liquids down to 10nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Particle size, concentration, Zeta potential and aggregation can all be analyzed while a fluorescence mode provides differentiation of labelled particles. This particle-by-particle methodology goes beyond traditional light scattering and other ensemble techniques in providing high-resolution particle size distributions.
NanoSight's comprehensive characterization matches the demands of complex biological systems, hence its wide application in development of drug delivery systems, of viral vaccines, in nanotoxicology and in biodiagnostics. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner.
NanoSight has a growing role in biodiagnostics, being proven in detection and speciation of nanovesicles (exosomes) and microvesicles. As functionalized nanoparticles increasingly fulfill their potential in biodiagnostics, NanoSight is ever more the analytical platform of choice.
NanoSight demonstrates worldwide success through rapid adoption of NTA, having installed more than 300 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes. In addition to this user base more than 250 third party papers citing NanoSight results consolidate NanoSight's leadership position in nanoparticle characterization. For more information, visit the NanoSight website (www.nanosight.com).